SCHEMBL6843988

SCHEMBL6843988

CCCC(=O)OOCC(O)CO

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.50
DUSP3 P51452 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
LMNA P02545 1/20 0.50
DGKA P23743 1/20 0.43
ALDH1A1 P00352 1/20 0.41
FAAH O00519 4/20 0.41
USP2 O75604 1/20 0.39
MAPT P10636 2/20 0.34
MAPK1 P28482 1/20 0.34
PRKCA P17252 3/20 0.33
PRKCE Q02156 1/20 0.33
PRKCQ Q04759 1/20 0.33
PRKCD Q05655 1/20 0.33
CNR2 P34972 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4198660 0.86 LMNA (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL7655873 0.86 LMNA (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL1232546 0.86 LMNA (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL5936305 0.86 LMNA (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL333190 0.86 LMNA (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL9179173 0.86 LMNA (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL4808325 0.84 LMNA (0.44) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL8443414 0.81 LMNA (0.39) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL7620059 0.81 LMNA (0.39) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL16758621 0.81 KDM4E (0.46) KDM4EDUSP3MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020060426-A1 AN ORAL PREPARATION CONTAINING SODIUM BUTYRATE NERR PHARMA SPOŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ (PL) 2020-03-26 WO disclosed
US-6770299-B1 Lipid matrix-drug conjugates particle for controlled release of active ingredient PHARMASOL GMBH (DE) 2004-08-03 US disclosed